GE Healthcare announced at RSNA 2012 receipt of U.S. Food and Drug Administration (FDA) clearance for its advanced imaging tool, FlightPlan for Liver. Developed to help make intricate liver embolization procedures simpler, FlightPlan for Liver has been commercially available in Europe, Latin America and Asia since 2011, with more than 30 installations in more than 10 countries.

Bracco Diagnostics Inc. is voluntarily initiating a Class I recall of nine lots of Isovue (iopamidol injection) pre-filled power injector syringes (Isovue PFS, to be used in combination with Stellant CT [computed tomography] injection systems) due to the presence of visible particles in syringes observed at the end of standard stability studies on retained samples. These products were distributed to wholesalers and distributors nationwide.

Clopidogrel Prasugrel TCT 2012 Smoking PARADOX Study Antiplatelet Therapy

Results of a study investigating the effects of smoking on the antiplatelet medications clopidogrel and prasugrel were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

A large observational study found the increased risk associated with dual antiplatelet therapy cessation after percutaneous coronary intervention (PCI) is tied to patient non-adherence, as opposed to physician-recommended discontinuation. Results of the PARIS registry were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

TeraRecon previewed a flexible new pay-as-you-go billing option for it cloud and laptop users of its iNtuition advanced visualization tools. The software supports physicians involved in TAVI/TAVR, EVAR and TEVAR, at the 39th Annual Veith Symposium in New York Nov. 14 – 16, 2012.

St. Jude Medical Inc. announced that the company’s EnligHTN renal denervation system provides a safe, effective and sustained reduction in office and ambulatory blood pressure measurements at six months. The new data was released in the Clinical Science and Special Reports Session during the annual American Heart Association (AHA) meeting.

TriVascular Inc. announced premarket approval (PMA) of the Ovation Abdominal Stent Graft System by the U.S. Food and Drug Administration (FDA) for the treatment of abdominal aortic aneurysms (AAA). Delivered through a 14 French (4.7 mm) outer diameter catheter, Ovation is the lowest profile commercially available system for EVAR.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now